Another topic of discussion that arises frequently when defining BMD measurements is that it should be performed every year or two in patients with chronic cholestasis with risk factors, patients who have been treated with glucocorticoids and liver transplants.
Además, parece apropiada la evaluación de la DMO en cirrosis biliar primaria, colestasis crónica, cirrosis y en individuos que presenten los factores de riesgo mencionados con anterioridad, o que se les haya realizado trasplante 19.